PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.75%
Negative revenue growth while QCOM stands at 9.09%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-8.29%
Negative gross profit growth while QCOM is at 9.05%. Joel Greenblatt would examine cost competitiveness or demand decline.
-0.24%
Negative EBIT growth while QCOM is at 5.56%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
0.24%
Operating income growth under 50% of QCOM's 5.56%. Michael Burry would be concerned about deeper cost or sales issues.
9.66%
Net income growth at 75-90% of QCOM's 12.78%. Bill Ackman would press for improvements to catch or surpass competitor performance.
11.27%
EPS growth at 75-90% of QCOM's 12.77%. Bill Ackman would push for improved profitability or share repurchases to catch up.
8.45%
Diluted EPS growth at 50-75% of QCOM's 12.77%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-1.01%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.59%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
8.09%
Maintaining or increasing dividends while QCOM cut them. John Neff might see a strong edge in shareholder returns.
-6.68%
Negative OCF growth while QCOM is at 14.93%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
0.76%
FCF growth under 50% of QCOM's 44.60%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
72.41%
10Y revenue/share CAGR under 50% of QCOM's 330.32%. Michael Burry would suspect a lasting competitive disadvantage.
34.31%
5Y revenue/share CAGR under 50% of QCOM's 91.69%. Michael Burry would suspect a significant competitive gap or product weakness.
16.04%
3Y revenue/share CAGR at 50-75% of QCOM's 31.75%. Martin Whitman would question if the firm lags behind competitor innovations.
177.75%
10Y OCF/share CAGR at 50-75% of QCOM's 327.88%. Martin Whitman might fear a structural deficiency in operational efficiency.
85.39%
5Y OCF/share CAGR above 1.5x QCOM's 17.24%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
1.19%
3Y OCF/share CAGR under 50% of QCOM's 7.85%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
120.11%
Below 50% of QCOM's 477.80%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
96.83%
5Y net income/share CAGR above 1.5x QCOM's 62.98%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
46.06%
Positive short-term CAGR while QCOM is negative. John Neff would see a clear advantage in near-term profit trajectory.
22.64%
Below 50% of QCOM's 250.25%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
19.66%
Below 50% of QCOM's 90.15%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
22.49%
3Y equity/share CAGR at 50-75% of QCOM's 35.57%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
511.63%
Dividend/share CAGR of 511.63% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
336.24%
5Y dividend/share CAGR above 1.5x QCOM's 110.32%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
29.79%
3Y dividend/share CAGR at 75-90% of QCOM's 36.48%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
-13.45%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
6.74%
Inventory shrinking or stable vs. QCOM's 18.39%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
5.95%
Asset growth 1.25-1.5x QCOM's 3.98%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
5.84%
Similar to QCOM's 6.13%. Walter Schloss finds parallel capital usage or profit distribution strategies.
No Data
No Data available this quarter, please select a different quarter.
-6.00%
Our R&D shrinks while QCOM invests at 1.23%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-0.26%
We cut SG&A while QCOM invests at 30.83%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.